Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025
Expands senior leadership team and board of directors to support next phase of growth Expands senior leadership team and board of directors to support next phase of growth
How does this quarter’s performance impact the consensus rating and target price set by analysts?
What are the potential regulatory or market risks that could offset the revenue growth?
How does this earnings release affect the short‑term technical chart patterns (e.g., support/resistance levels) for MILE?
27 days ago